Advertisement

Index by author

January 01, 1989; Volume 248,Issue 1

A

  1. Adams, M L

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  2. Amrick, C L

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  3. Anderson, C B

    1. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
      M J Mangino, E M Brunt, P Von Doersten and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 23-28;

  4. Aram, J A

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  5. Axelrod, J

    1. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
      C C Felder, P A Jose and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 171-175;

B

  1. Baird, A W

    1. Bradykinin stimulates electrogenic bicarbonate secretion by the guinea pig gallbladder.
      A W Baird and H S Margolius
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 268-272;

  2. Barnes, P J

    1. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase.
      N Frossard, K J Rhoden and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 292-298;

  3. Basile, A S

    1. Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.
      A S Basile, G T Bolger, H W Lueddens and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 463-469;

  4. Baskin, E P

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  5. Bazil, C W

    1. Effects of clinically effective concentrations of halothane on adrenergic and cholinergic synapses in rat brain in vitro.
      C W Bazil and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 143-148;

  6. Begnis, R

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  7. Bell, R D

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  8. Benigni, A

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  9. Bennett, D A

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  10. Benson, R W

    1. Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay.
      D W Potter, N R Pumford, J A Hinson, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 182-189;
    2. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
      N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;

  11. Berry, R G

    1. Gradient in the effects of ethyl alcohol on canine gastric antral circular muscles.
      K M Sanders, J B Reed and R G Berry
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 202-207;

  12. Bigelow, G E

    1. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 127-134;

  13. Birkett, D J

    1. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
      A Lelo, G Kjellen, D J Birkett and J O Miners
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 315-319;

  14. Black, E W

    1. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
      E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;

  15. Bloomquist, W

    1. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
      M L Cohen, W Bloomquist, J S Gidda and W Lacefield
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 197-201;

  16. Bohmaker, K

    1. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
      K Bohmaker, T Puza, M Goldstein and E Meller
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 97-103;

  17. Bolger, G T

    1. Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.
      A S Basile, G T Bolger, H W Lueddens and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 463-469;

  18. Bonetti, E P

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  19. Borsini, F

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  20. Borson, D B

    1. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
      T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;

  21. Bosin, T R

    1. Oxidant stress stimulates active transport of serotonin by platelets.
      T R Bosin
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 67-72;

  22. Braunwalder, A F

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  23. Breese, G R

    1. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
      G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;

  24. Brown, A M

    1. Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.
      D Rampe, A Skattebøl, D J Triggle and A M Brown
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 164-170;

  25. Brunt, E M

    1. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
      M J Mangino, E M Brunt, P Von Doersten and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 23-28;

  26. Burkard, W P

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;
    2. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;

C

  1. Chambers, L L

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat.
      M R Lakshman, S J Chirtel, L L Chambers and P J Coutlakis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 62-66;

  2. Chirtel, S J

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat.
      M R Lakshman, S J Chirtel, L L Chambers and P J Coutlakis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 62-66;

  3. Cicero, T J

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  4. Clusin, W

    1. Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts.
      S C Dennis, W A Coetzee, J W de Jong, W Clusin and L H Opie
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 372-377;

  5. Coetzee, W A

    1. Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts.
      S C Dennis, W A Coetzee, J W de Jong, W Clusin and L H Opie
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 372-377;

  6. Cohen, M L

    1. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
      M L Cohen, W Bloomquist, J S Gidda and W Lacefield
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 197-201;

  7. Corcoran, G B

    1. Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat.
      G B Corcoran and D E Salazar
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 17-22;

  8. Costa, T

    1. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
      F Passarelli and T Costa
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 299-305;

  9. Coutlakis, P J

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat.
      M R Lakshman, S J Chirtel, L L Chambers and P J Coutlakis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 62-66;

  10. Crews, F T

    1. Cholinergic receptors in renal medullary collecting duct cells.
      S McArdle, L C Garg and F T Crews
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 12-16;

D

  1. Da Prada, M

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;
    2. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;

  2. de Jong, J W

    1. Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts.
      S C Dennis, W A Coetzee, J W de Jong, W Clusin and L H Opie
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 372-377;

  3. Dennis, S C

    1. Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts.
      S C Dennis, W A Coetzee, J W de Jong, W Clusin and L H Opie
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 372-377;

  4. Djokic, T D

    1. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
      T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;

  5. Dorr, M B

    1. Contribution of metabolites to the route- and time-dependent hepatic effects of di-(2-ethylhexyl)phthalate in the rat.
      G M Pollack, D D Shen and M B Dorr
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 176-181;

  6. Douer, D

    1. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
      E Somekh, D Douer, N Shaked and E Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 415-418;

  7. Drewett, J G

    1. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
      J G Drewett, G J Trachte and G R Marchand
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 135-142;

  8. Dumarey, C

    1. Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.
      M Pretolani, J Lefort, C Dumarey and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 353-359;

  9. Duncan, G E

    1. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
      G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;

  10. Dusser, D J

    1. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
      T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;

E

  1. Eisenhofer, G

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  2. Escalante, B

    1. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
      B Escalante, W C Sessa, J R Falck, P Yadagiri and M L Schwartzman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 229-232;

  3. Evans, S M

    1. Discriminative stimulus properties of midazolam in the pigeon.
      S M Evans and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 29-38;

F

  1. Falck, J R

    1. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
      B Escalante, W C Sessa, J R Falck, P Yadagiri and M L Schwartzman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 229-232;

  2. Farber, N E

    1. Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium.
      N E Farber and G J Gross
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 39-43;

  3. Fassberg, J B

    1. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
      G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;

  4. Feinberg, H

    1. Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: the inhibitory effect of aspirin.
      S L Lee, S Levitsky and H Feinberg
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 44-49;

  5. Felder, C C

    1. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
      C C Felder, P A Jose and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 171-175;

  6. Ferguson, A E

    1. Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
      M T Moslen, R F Whitehead, A E Ferguson and M F Kanz
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 157-163;

  7. Finn, R

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  8. Frossard, N

    1. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase.
      N Frossard, K J Rhoden and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 292-298;

  9. Fuller, R W

    1. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
      R W Fuller and K W Perry
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 50-56;

G

  1. Garattini, S

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  2. Garcia, M L

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  3. Garg, L C

    1. Cholinergic receptors in renal medullary collecting duct cells.
      S McArdle, L C Garg and F T Crews
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 12-16;

  4. Garrett, R L

    1. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
      E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;

  5. Gidda, J S

    1. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
      M L Cohen, W Bloomquist, J S Gidda and W Lacefield
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 197-201;

  6. Giles, R E

    1. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
      R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
    2. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

  7. Giroud, J P

    1. Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats.
      E Vannier, M Roch-Arveiller, B Molinie, B Terlain and J P Giroud
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 286-291;

  8. Giuliani, S

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  9. Gogas, K R

    1. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
      K R Gogas and L B Hough
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 262-267;

  10. Goldstein, D S

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  11. Goldstein, M

    1. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
      K Bohmaker, T Puza, M Goldstein and E Meller
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 97-103;

  12. Goto, K

    1. Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats.
      A Saito, T Masaki, Y Uchiyama, T J Lee and K Goto
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 455-462;

  13. Gousse, A

    1. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors.
      J Latifpour, A Gousse, S Kondo, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 81-88;

  14. Graf, P D

    1. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
      T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;

  15. Gragnani, L

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  16. Greenblatt, D J

    1. Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain.
      L G Miller, D J Greenblatt, R B Roy, F Lopez and L Wecker
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 1-6;

  17. Gross, G J

    1. Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium.
      N E Farber and G J Gross
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 39-43;

  18. Gulya, K

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

H

  1. Haefely, W E

    1. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;

  2. Hashimoto, H

    1. Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats: no evidence for involvement of hypothyroidism.
      N Sato, H Hashimoto, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 367-371;

  3. Hawkins, K N

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  4. Heaney, L A

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  5. Hefti, F

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  6. Heishman, S J

    1. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 127-134;

  7. Hellebrekers, L J

    1. Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.
      L J Hellebrekers, W E van den Brom and J A Mol
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 329-333;

  8. Hinson, J A

    1. Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay.
      D W Potter, N R Pumford, J A Hinson, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 182-189;
    2. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
      N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;

  9. Hirai, K

    1. Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
      S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;

  10. Hollenberg, M D

    1. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
      M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;

  11. Horohonich, S

    1. Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
      E H Ohlstein, S Horohonich, R J Shebuski and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 233-239;

  12. Hough, L B

    1. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
      K R Gogas and L B Hough
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 262-267;

  13. Hovevey-Sion, D

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  14. Hruby, V J

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  15. Hwang, T F

    1. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
      R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
    2. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

I

  1. Ilett, K F

    1. In vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment.
      P T Reeves, R F Minchin and K F Ilett
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 348-352;

  2. Itoh, H

    1. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
      M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;

J

  1. Jenden, D J

    1. Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. I. Recovery in vivo and in cell culture.
      J J Waite and D J Jenden
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 111-118;
    2. Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. II. Recovery in broken cell preparations.
      J J Waite and D J Jenden
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 119-126;

  2. Johanson, C E

    1. Discriminative stimulus properties of midazolam in the pigeon.
      S M Evans and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 29-38;

  3. Jose, P A

    1. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
      C C Felder, P A Jose and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 171-175;

K

  1. Kacew, S

    1. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat.
      S Kacew
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 360-366;

  2. Kaczorowski, G J

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  3. Kanz, M F

    1. Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
      M T Moslen, R F Whitehead, A E Ferguson and M F Kanz
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 157-163;

  4. Kau, S T

    1. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
      R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
    2. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

  5. Kazmierski, W

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  6. Keith, R A

    1. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
      R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
    2. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

  7. Keller, H H

    1. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;

  8. Kennedy, R H

    1. Aging: ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat left atrial muscle.
      R H Kennedy and E Seifen
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 104-110;

  9. Kettler, R

    1. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;

  10. Kirk, K L

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  11. Kjellen, G

    1. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
      A Lelo, G Kjellen, D J Birkett and J O Miners
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 315-319;

  12. Kleven, M S

    1. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
      M S Kleven and S B Sparber
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 273-277;

  13. Knapp, R J

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  14. Kondo, S

    1. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors.
      J Latifpour, A Gousse, S Kondo, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 81-88;

  15. Kopia, G A

    1. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
      G A Kopia and R E Valocik
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 215-221;

  16. Kopin, I J

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  17. Kvietys, P R

    1. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
      E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;

L

  1. Lacefield, W

    1. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
      M L Cohen, W Bloomquist, J S Gidda and W Lacefield
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 197-201;

  2. Lakshman, M R

    1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat.
      M R Lakshman, S J Chirtel, L L Chambers and P J Coutlakis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 62-66;

  3. Latifpour, J

    1. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors.
      J Latifpour, A Gousse, S Kondo, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 81-88;

  4. Lecci, A

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  5. Lederis, K

    1. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
      M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;

  6. Lee, S L

    1. Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: the inhibitory effect of aspirin.
      S L Lee, S Levitsky and H Feinberg
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 44-49;

  7. Lee, T J

    1. Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats.
      A Saito, T Masaki, Y Uchiyama, T J Lee and K Goto
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 455-462;

  8. Lefort, J

    1. Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.
      M Pretolani, J Lefort, C Dumarey and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 353-359;

  9. Lelo, A

    1. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
      A Lelo, G Kjellen, D J Birkett and J O Miners
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 315-319;

  10. Levitsky, S

    1. Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: the inhibitory effect of aspirin.
      S L Lee, S Levitsky and H Feinberg
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 44-49;

  11. Liccione, J J

    1. Manganese-mediated increase in the rat brain mitochondrial cytochrome P-450 and drug metabolism activity: susceptibility of the striatum.
      J J Liccione and M D Maines
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 222-228;

  12. Liebson, I A

    1. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 127-134;

  13. Livio, M

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  14. Lodge, D

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  15. Loo, P S

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  16. Lopez, F

    1. Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain.
      L G Miller, D J Greenblatt, R B Roy, F Lopez and L Wecker
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 1-6;

  17. Lueddens, H W

    1. Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.
      A S Basile, G T Bolger, H W Lueddens and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 463-469;

  18. Lui, G K

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

M

  1. Maggi, C A

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  2. Maines, M D

    1. Manganese-mediated increase in the rat brain mitochondrial cytochrome P-450 and drug metabolism activity: susceptibility of the striatum.
      J J Liccione and M D Maines
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 222-228;

  3. Mangino, M J

    1. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
      M J Mangino, E M Brunt, P Von Doersten and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 23-28;

  4. Marchand, G R

    1. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
      J G Drewett, G J Trachte and G R Marchand
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 135-142;

  5. Margolius, H S

    1. Bradykinin stimulates electrogenic bicarbonate secretion by the guinea pig gallbladder.
      A W Baird and H S Margolius
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 268-272;

  6. Martin, D

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  7. Martin, J R

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  8. Masaki, T

    1. Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats.
      A Saito, T Masaki, Y Uchiyama, T J Lee and K Goto
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 455-462;

  9. McArdle, S

    1. Cholinergic receptors in renal medullary collecting duct cells.
      S McArdle, L C Garg and F T Crews
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 12-16;

  10. Meehan, A G

    1. Interaction of the prejunctional inhibitory action of 5-hydroxytryptamine on noradrenergic transmission with neuronal amine uptake in rabbit isolated ear artery.
      A G Meehan and D F Story
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 342-347;

  11. Meli, A

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  12. Meli, P

    1. Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
      C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;

  13. Meller, E

    1. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
      K Bohmaker, T Puza, M Goldstein and E Meller
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 97-103;

  14. Meyer, E R

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  15. Miletich, R

    1. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
      G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;

  16. Millar, J

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  17. Miller, B T

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  18. Miller, L G

    1. Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain.
      L G Miller, D J Greenblatt, R B Roy, F Lopez and L Wecker
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 1-6;

  19. Minchin, R F

    1. In vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment.
      P T Reeves, R F Minchin and K F Ilett
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 348-352;

  20. Minematsu, R

    1. Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
      S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;

  21. Miners, J O

    1. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
      A Lelo, G Kjellen, D J Birkett and J O Miners
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 315-319;

  22. Minneman, K P

    1. Effects of clinically effective concentrations of halothane on adrenergic and cholinergic synapses in rat brain in vitro.
      C W Bazil and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 143-148;

  23. Miyake, K

    1. Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
      S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;

  24. Mol, J A

    1. Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.
      L J Hellebrekers, W E van den Brom and J A Mol
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 329-333;

  25. Molinie, B

    1. Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats.
      E Vannier, M Roch-Arveiller, B Molinie, B Terlain and J P Giroud
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 286-291;

  26. Morelli, C

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  27. Morita, T

    1. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors.
      J Latifpour, A Gousse, S Kondo, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 81-88;

  28. Moslen, M T

    1. Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
      M T Moslen, R F Whitehead, A E Ferguson and M F Kanz
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 157-163;

  29. Muggli-Maniglio, D

    1. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;

  30. Müller, R K

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  31. Muramatsu, I

    1. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
      M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;

  32. Murthy, V S

    1. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
      R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
    2. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

N

  1. Nadel, J A

    1. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
      T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;

  2. Nakashima, M

    1. Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats: no evidence for involvement of hypothyroidism.
      N Sato, H Hashimoto, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 367-371;

  3. Nock, B

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  4. Norman, J A

    1. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
      E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;

O

  1. O'Connor, L

    1. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
      T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;

  2. Ohlstein, E H

    1. Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
      E H Ohlstein, S Horohonich, R J Shebuski and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 233-239;

  3. Opie, L H

    1. Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts.
      S C Dennis, W A Coetzee, J W de Jong, W Clusin and L H Opie
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 372-377;

P

  1. Passarelli, F

    1. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
      F Passarelli and T Costa
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 299-305;

  2. Patel, P

    1. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
      M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;

  3. Paul, I A

    1. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
      G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;

  4. Pelton, J T

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  5. Perry, K W

    1. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
      R W Fuller and K W Perry
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 50-56;

  6. Pohler, G

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  7. Polc, P

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  8. Pollack, G M

    1. Contribution of metabolites to the route- and time-dependent hepatic effects of di-(2-ethylhexyl)phthalate in the rat.
      G M Pollack, D D Shen and M B Dorr
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 176-181;

  9. Potter, D W

    1. Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay.
      D W Potter, N R Pumford, J A Hinson, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 182-189;
    2. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
      N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;

  10. Powell, K R

    1. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
      G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;

  11. Pretolani, M

    1. Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.
      M Pretolani, J Lefort, C Dumarey and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 353-359;

  12. Pumford, N R

    1. Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay.
      D W Potter, N R Pumford, J A Hinson, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 182-189;
    2. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
      N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;

  13. Puza, T

    1. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
      K Bohmaker, T Puza, M Goldstein and E Meller
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 97-103;

R

  1. Rampe, D

    1. Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.
      D Rampe, A Skattebøl, D J Triggle and A M Brown
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 164-170;

  2. Reed, J B

    1. Gradient in the effects of ethyl alcohol on canine gastric antral circular muscles.
      K M Sanders, J B Reed and R G Berry
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 202-207;

  3. Reeves, P T

    1. In vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment.
      P T Reeves, R F Minchin and K F Ilett
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 348-352;

  4. Remuzzi, G

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  5. Rhoden, K J

    1. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase.
      N Frossard, K J Rhoden and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 292-298;

  6. Roberts, D W

    1. Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay.
      D W Potter, N R Pumford, J A Hinson, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 182-189;
    2. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
      N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;

  7. Roch-Arveiller, M

    1. Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats.
      E Vannier, M Roch-Arveiller, B Molinie, B Terlain and J P Giroud
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 286-291;

  8. Rossini, M

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;

  9. Rowland, K L

    1. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
      N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;

  10. Roy, R B

    1. Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain.
      L G Miller, D J Greenblatt, R B Roy, F Lopez and L Wecker
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 1-6;

  11. Rubinstein, E

    1. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
      E Somekh, D Douer, N Shaked and E Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 415-418;

  12. Ruffolo, R R

    1. Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
      E H Ohlstein, S Horohonich, R J Shebuski and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 233-239;

  13. Russel, F G

    1. Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.
      F G Russel, A C Wouterse and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 436-446;

  14. Russell, F G

    1. Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines.
      F G Russell, A C Wouterse and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 428-435;

S

  1. Saito, A

    1. Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats.
      A Saito, T Masaki, Y Uchiyama, T J Lee and K Goto
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 455-462;

  2. Salama, A I

    1. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
      R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
    2. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

  3. Salazar, D E

    1. Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat.
      G B Corcoran and D E Salazar
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 17-22;

  4. Sanders, K M

    1. Gradient in the effects of ethyl alcohol on canine gastric antral circular muscles.
      K M Sanders, J B Reed and R G Berry
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 202-207;

  5. Sano, I

    1. Cholecystokinin, but not gastrin, induces gamma-aminobutyric acid release from myenteric neurons of the guinea pig ileum.
      I Sano, K Taniyama and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 378-383;

  6. Sato, N

    1. Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats: no evidence for involvement of hypothyroidism.
      N Sato, H Hashimoto, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 367-371;

  7. Sawynok, J

    1. Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
      M I Sweeney, T D White and J Sawynok
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 447-454;

  8. Schaffner, R

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  9. Scherschlicht, R

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

  10. Schmutz, M

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  11. Schwartzman, M L

    1. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
      B Escalante, W C Sessa, J R Falck, P Yadagiri and M L Schwartzman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 229-232;

  12. Seifen, E

    1. Aging: ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat left atrial muscle.
      R H Kennedy and E Seifen
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 104-110;

  13. Sekizawa, K

    1. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
      T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;

  14. Sessa, W C

    1. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
      B Escalante, W C Sessa, J R Falck, P Yadagiri and M L Schwartzman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 229-232;

  15. Shaked, N

    1. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
      E Somekh, D Douer, N Shaked and E Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 415-418;

  16. Shebuski, R J

    1. Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
      E H Ohlstein, S Horohonich, R J Shebuski and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 233-239;

  17. Shen, D D

    1. Contribution of metabolites to the route- and time-dependent hepatic effects of di-(2-ethylhexyl)phthalate in the rat.
      G M Pollack, D D Shen and M B Dorr
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 176-181;

  18. Shimizu, K

    1. Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
      S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;

  19. Skattebøl, A

    1. Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.
      D Rampe, A Skattebøl, D J Triggle and A M Brown
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 164-170;

  20. Skolnick, P

    1. Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.
      A S Basile, G T Bolger, H W Lueddens and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 463-469;

  21. Somekh, E

    1. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
      E Somekh, D Douer, N Shaked and E Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 415-418;

  22. Sparber, S B

    1. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
      M S Kleven and S B Sparber
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 273-277;

  23. Stein, R B

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  24. Stitzer, M L

    1. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 127-134;

  25. Story, D F

    1. Interaction of the prejunctional inhibitory action of 5-hydroxytryptamine on noradrenergic transmission with neuronal amine uptake in rabbit isolated ear artery.
      A G Meehan and D F Story
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 342-347;

  26. Strada, S J

    1. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
      E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;

  27. Stumpf, W E

    1. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
      G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;

  28. Sweeney, M I

    1. Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
      M I Sweeney, T D White and J Sawynok
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 447-454;

T

  1. Takeo, S

    1. Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
      S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;

  2. Takiguchi, Y

    1. Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats: no evidence for involvement of hypothyroidism.
      N Sato, H Hashimoto, Y Takiguchi and M Nakashima
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 367-371;

  3. Tanaka, C

    1. Cholecystokinin, but not gastrin, induces gamma-aminobutyric acid release from myenteric neurons of the guinea pig ileum.
      I Sano, K Taniyama and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 378-383;

  4. Taniyama, K

    1. Cholecystokinin, but not gastrin, induces gamma-aminobutyric acid release from myenteric neurons of the guinea pig ileum.
      I Sano, K Taniyama and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 378-383;

  5. Tanonaka, K

    1. Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
      S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;

  6. Terlain, B

    1. Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats.
      E Vannier, M Roch-Arveiller, B Molinie, B Terlain and J P Giroud
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 286-291;

  7. Thompson, T N

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  8. Thompson, W J

    1. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
      E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;

  9. Tomczyk, M

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  10. Trachte, G J

    1. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
      J G Drewett, G J Trachte and G R Marchand
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 135-142;

  11. Triggle, D J

    1. Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.
      D Rampe, A Skattebøl, D J Triggle and A M Brown
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 164-170;

U

  1. Uchiyama, Y

    1. Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats.
      A Saito, T Masaki, Y Uchiyama, T J Lee and K Goto
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 455-462;

V

  1. Valocik, R E

    1. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
      G A Kopia and R E Valocik
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 215-221;

  2. van den Brom, W E

    1. Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.
      L J Hellebrekers, W E van den Brom and J A Mol
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 329-333;

  3. van Ginneken, C A

    1. Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines.
      F G Russell, A C Wouterse and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 428-435;
    2. Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.
      F G Russel, A C Wouterse and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 436-446;

  4. Vannier, E

    1. Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats.
      E Vannier, M Roch-Arveiller, B Molinie, B Terlain and J P Giroud
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 286-291;

  5. Vargaftig, B B

    1. Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.
      M Pretolani, J Lefort, C Dumarey and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 353-359;

  6. Von Doersten, P

    1. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
      M J Mangino, E M Brunt, P Von Doersten and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 23-28;

W

  1. Waite, J J

    1. Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. I. Recovery in vivo and in cell culture.
      J J Waite and D J Jenden
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 111-118;
    2. Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. II. Recovery in broken cell preparations.
      J J Waite and D J Jenden
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 119-126;

  2. Wallace, A A

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  3. Wan, Y P

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  4. Wasley, J W

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  5. Wecker, L

    1. Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain.
      L G Miller, D J Greenblatt, R B Roy, F Lopez and L Wecker
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 1-6;

  6. Weiss, R M

    1. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors.
      J Latifpour, A Gousse, S Kondo, T Morita and R M Weiss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 81-88;

  7. White, T D

    1. Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
      M I Sweeney, T D White and J Sawynok
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 447-454;

  8. Whitehead, R F

    1. Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
      M T Moslen, R F Whitehead, A E Ferguson and M F Kanz
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 157-163;

  9. Wilkerson, R D

    1. Cardiovascular effects of cocaine: enhancement by yohimbine and atropine.
      R D Wilkerson
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 57-61;

  10. Williams, M

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  11. Wilson, D E

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

  12. Winquist, R J

    1. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
      R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;

  13. Wouterse, A C

    1. Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines.
      F G Russell, A C Wouterse and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 428-435;
    2. Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.
      F G Russel, A C Wouterse and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 436-446;

  14. Wurm, R

    1. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

  15. Wyss, P C

    1. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
      W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;

Y

  1. Yadagiri, P

    1. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
      B Escalante, W C Sessa, J R Falck, P Yadagiri and M L Schwartzman
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 229-232;

  2. Yamamura, H I

    1. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
      K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;

  3. Yang, S G

    1. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
      M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;

  4. Yokoyoma, N

    1. CGS 20625, a novel pyrazolopyridine anxiolytic.
      M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;

Z

  1. Zagar, M E

    1. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
      V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;

  2. Zeman, S

    1. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
      J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;

  3. Zoja, C

    1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
      M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;
Back to top

In this issue